Previous 10 | Next 10 |
Royalty Pharma (NASDAQ:RPRX) declares $0.19/share quarterly dividend, in line with previous. Forward yield 1.72% Payable June 15; for shareholders of record May 20; ex-div May 19. See RPRX Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Royalty Pharma de...
NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2022 of $0.19 per Class A ordinary share. The dividend will be paid on June 15, 2022, to shareholders of reco...
Royalty Pharma (RPRX +3.4%) upgraded to overweight by JP Morgan based on increasingly attractive relative valuation and an improving business development landscape. Bank elaborates, "On the capital deployment front, company holds an enviable leadership position in the expanding bi...
NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2022 financial results on Thursday, May 5, 2022 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:...
Morgan Stanley has upgraded Royalty Pharma (NASDAQ:RPRX +1.0%) to Overweight from Equal-weight, highlighting its valuation discrepancy relative to the sector. The analyst Terence Flynn notes that the buyer of biopharmaceutical royalties generated $2.6 billion of royalty revenue in 2021 thanks...
Royalty Pharma Announces Charitable Alliance with The Leukemia & Lymphoma Society (LLS) To Advance Initiatives that Address Healthcare Disparities in Blood Cancer Care and Treatment Royalty Pharma Announces Charitable Alliance with The Leukemia & Lymphoma Society (LLS) T...
This Buffett holdings list from Kiplinger first appeared 2/14/22 on line. YCharts and Dogs of The Dow also track this Buffett/Berkshire batch. Here is your update from 3/21/22 YCharts data. 28 of 44 current Berkshire-Hathaway-owned-stocks pay dividends. As of 3/21/22, the top-ten rang...
Halvorsen's 13F portfolio value decreased from $36.04B to $34.49B this quarter. The number of positions increased from 96 to 107. Viking Global added Twilio, Workday, and Aon plc while dropping Fidelity National Information Services and Snowflake. The top three positions are Ginkg...
NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at Cowen’s 42 nd Annual Health Care Conference on March 8, 2022 at 11:10 a.m. ET. The webcast will be accessible from Royalt...
Royalty Pharma is one of a handful of healthcare companies that I was interested in since they announced their IPO. The company is profitable and offers a dividend. Unlike other biopharma IPOs, Royalty's business is to buy biopharmaceutical royalties rather than take the money to deve...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Molly Sawaya as Executive Vice President, Head of Human Capital. Molly joins Royalty Pharma from Hudson Bay Capital, where she was a Managing Director and Head of Colleague Experie...
2024-07-24 08:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...